| Literature DB >> 26216017 |
David A Perrey1, Ann M Decker1, Jun-Xu Li2, Brian P Gilmour1, Brian F Thomas1, Danni L Harris1, Scott P Runyon1, Yanan Zhang3.
Abstract
Selective antagonism of the orexin 1 (OX1) receptor has been proposed as a potential mechanism for treatment of drug addiction. We have previously reported studies on the structure-activity relationships of tetrahydroisoquinoline-based antagonists. In this report, we elucidated the respective role of the 6- and 7-substitutions by preparation of a series of either 6-substituted tetrahydroisoquinolines (with no 7-substituents) or vice versa. We found that 7-substituted tetrahydroisoquinolines showed potent antagonism of OX1, indicating that the 7-position is important for OX1 antagonism (10 c, Ke = 23.7 nM). While the 6-substituted analogs were generally inactive, several 6-amino compounds bearing ester groups showed reasonable potency (26 a, Ke = 427 nM). Further, we show evidence that suggests several compounds initially displaying insurmountable antagonism at the OX1 receptor are competitive antagonists with slow dissociation rates.Entities:
Keywords: Antagonist; Orexin; Selective; Tetrahydroisoquinoline
Mesh:
Substances:
Year: 2015 PMID: 26216017 PMCID: PMC4554834 DOI: 10.1016/j.bmc.2015.07.013
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641